India’s Serum Institute First To Test Coronavirus Vaccine
Human Trials Expected In Six Months Serum Institute of India Pvt Ltd (SII) – the world’s largest vaccine manufacturer by number of doses produced and sold globally – announced that a vaccine candidate for the novel coronavirus (COVID-19) is expected to progress to human trials phase within six months. The vaccine candidate developed by SIIPL,…